COMPLEMENT-DEPENDENT PHAGOCYTOSIS OF LIPOSOMES BY MACROPHAGES - SUPPRESSIVE EFFECTS OF STEALTH LIPIDS

被引:48
作者
WASSEF, NM
MATYAS, GR
ALVING, CR
机构
[1] Department of Membrane Biochemistry, Walter Reed Army Institute of Research, Washington
关键词
D O I
10.1016/S0006-291X(05)80266-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have previously reported that complement-opsonized liposomes composed of dimyristoyl phosphatidylcholine and cholesterol are actively phagocytozed by murine peritoneal macrophages and that such complement-induced phagocytosis can be suppressed by the presence of liposomal phosphatidylinositol (Proc. Natl. Acad. Sci. USA 81, 1984). We now report suppressive effects of other liposomal lipids, including monosialoganglioside (GM1) and sulfogalactosylceramide. Complement-dependent phagocytosis was almost completely suppressed by liposomes containing GM1 or phosphatidylinositol and partially suppressed when liposomes contained sulfogalactosylceramide. Although the mechanism of suppression of complement-induced phagocytosis by these liposomal lipids is not yet completely understood, it does not seem to involve the early stages of complement activation resulting in opsonization of liposomes with complement. We conclude that suppression of complement-induced phagocytosis by phosphatidylinositol, GM1, or sulfogalactosylceramide occurs at a step after liposome opsonization. © 1991 Academic Press, Inc.
引用
收藏
页码:866 / 874
页数:9
相关论文
共 24 条
[1]  
ALLEN T M, 1989, P405
[2]   LIPOSOMES WITH PROLONGED CIRCULATION TIMES - FACTORS AFFECTING UPTAKE BY RETICULOENDOTHELIAL AND OTHER TISSUES [J].
ALLEN, TM ;
HANSEN, C ;
RUTLEDGE, J .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 981 (01) :27-35
[3]   DELIVERY OF LIPOSOME-ENCAPSULATED DRUGS TO MACROPHAGES [J].
ALVING, CR .
PHARMACOLOGY & THERAPEUTICS, 1983, 22 (03) :407-424
[4]  
ALVING CR, 1984, LIPOSOME TECHNOLOGY, V2, P157
[5]   INFLUENCE OF RETINAL ON COMPLEMENT-DEPENDENT IMMUNE DAMAGE TO LIPOSOMES [J].
CONRAD, DH ;
ALVING, CR ;
WIRTZ, GH .
BIOCHIMICA ET BIOPHYSICA ACTA, 1974, 332 (01) :36-46
[6]   LIPOSOME FORMULATIONS WITH PROLONGED CIRCULATION TIME IN BLOOD AND ENHANCED UPTAKE BY TUMORS [J].
GABIZON, A ;
PAPAHADJOPOULOS, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (18) :6949-6953
[7]   DYNAMICS OF ANTIBODY-MEDIATED AND LECTIN-MEDIATED ENDOCYTOSIS OF HAPTEN-CONTAINING LIPOSOMES BY MURINE MACROPHAGES [J].
GEIGER, B ;
GITLER, C ;
CALEF, E ;
ARNON, R .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (09) :710-716
[8]   INTERACTIONS OF LIPOSOMES WITH THE RETICULOENDOTHELIAL SYSTEM .2. NONSPECIFIC AND RECEPTOR-MEDIATED UPTAKE OF LIPOSOMES BY MOUSE PERITONEAL-MACROPHAGES [J].
HSU, MJ ;
JULIANO, RL .
BIOCHIMICA ET BIOPHYSICA ACTA, 1982, 720 (04) :411-419
[9]   BINDING REACTION BETWEEN THE 3RD HUMAN-COMPLEMENT PROTEIN AND SMALL MOLECULES [J].
LAW, SKA ;
MINICH, TM ;
LEVINE, RP .
BIOCHEMISTRY, 1981, 20 (26) :7457-7463
[10]  
LEDEEN RW, 1982, METHOD ENZYMOL, V83, P139